SARcode Bioscience
SARcode Corporation is a private San Francisco based biopharmaceutical company engaged in the development of a novel class of small molecule lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; αLβ2) antagonists as a topical agent for the...Founded in 2006
Homepage: http://www.sarcode.com
Total money raised: $73M
94005
1000 Marina Blvd.
Suite 250
Brisbane
USA CA
Suite 250
Brisbane
USA CA
Updated on Jul 18, 2011
SARcode Bioscience at CrunchBase
Quinton Oswald CEOSARcode Bioscience at CrunchBase
Past
March, 2013
SARcode Bioscience was acquired by Shire
for $160M
Shire to Acquire Dry-Eye Drug Developer SARcode Bioscience 
pevc.dowjones.com
July, 2011
SARcode Bioscience raised $44M in a Series B round from Sofinnova Ventures, Rho Capital Partners, Alta Partners, and Clarus Ventures
SARcode Bioscience Closes $44M Series B Financing 
finsmes.com
December, 2006
SARcode Bioscience raised $29M in unattributed round from Alta Partners and Clarus Ventures
SARcode secured $25 million in financing 
sarcode.com
2006
SARcode Bioscience was founded in 2006